门诊森田心理辅助疗法对ⅢB型前列腺炎的疗效探讨(附136例报告)  

Molida Therapy in the Out-patient Department for Patients with ⅢB Prostatitis

作　　者：张晨光[1] 张天禹[2] 杨燕伟[2] 余家琦[1] 

机构地区：[1]浙江大学医学院附属第一医院泌尿外科,浙江杭州310003 [2]桂林医学院附属医院泌尿外科,广西桂林541001

出　　处：《中华男科学杂志》2006年第8期714-716,共3页National Journal of Andrology

摘　　要：目的:了解门诊森田疗法对ⅢB型前列腺炎的辅助疗效。方法:将136例确诊为ⅢB型前列腺炎且伴有不同程度心理障碍的患者随机分为:A组,常规治疗+森田疗法组(n=68);B组,常规治疗组(n=68)。分析2组间症状自评量表(SCL-90)、焦虑自评量表(SAS)和抑郁自评量表(SDS)评分变化和前列腺痛症状缓解情况。结果:治疗8周后,A组的SCL-90、SAS、SDS自测表评分分别为(70.5±22.3)、(18.7±8.5)、(21.4±9.0)分,均较治疗前下降,并低于B组,差异有显著性(P<0.05),A组的前列腺痛症状缓解有效率和显效率分别为100%、72.1%,均优于B组(P<0.05)。结论:门诊森田疗法有助于改善ⅢB型前列腺炎患者的心理障碍,提高治疗效果。Objective ： To study the therapeutic effect of Molida therapy in the out-patient department for patients with Ⅲ B prostatitis. Methods ： One hundred and thirty-six patients with ⅢB prostatis accompanied with psychological disorder of different degrees were divided into two groups： Group A （68 cases）, treated with routine drug and Molida therapy, and Group B （68 cases） , treated with routine drug only. The therapeutic effects of the two groups were analyzed. Results ： After an 8-week treatment, the scores of self-feeling symptoms of SCL-90, SAS and SDS in Group A were 70.5±22.3, 18.7 ± 8.5 and 21.4 ± 9.0, respectively, significantly lower than those in Group B （P 〈 0.05 ） and the rates of efficacy and obvious efficacy in alleviating prostatodynia in Group A were 100% and 72.1%, respectively, both higher than in Group B （ P 〈 0.05 ）. Conclusion ： Molida therapy in the out-patient department is useful in improving the psychological disorder and enhancing the therapeutic effect for patients with ⅢB prostatitis.

关 键 词：前列腺炎 前列腺痛 森田疗法 

分 类 号：R395.5[哲学宗教—心理学] R697.3[医药卫生—医学心理学]